Aust Fam Physician. 2017;46(5):277-281.


Background: Rosacea is a chronic and common cutaneous condition characterised by symptoms of facial flushing and a broad spectrum of clinical signs. The clinical presentation for rosacea is varied, and there are four primary subtypes, which may overlap - erythrotelangiectatic, inflammatory, phymatous and ocular. It is important to recognise the different subtypes because of the differences in therapy.

Objective: The objective of this article is to provide evidence-based clinical updates to clinicians, specifically general practitioners (GPs), to assist with their everyday practice, and effective assessment and treatment of rosacea.

Discussion: Therapeutic modalities are chosen on the basis of the subtypes and clinical features identified; often a combination of these therapies is required.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Brimonidine Tartrate / pharmacology
  • Brimonidine Tartrate / therapeutic use
  • Diagnosis, Differential
  • Doxycycline / pharmacology
  • Doxycycline / therapeutic use
  • Humans
  • Isotretinoin / pharmacology
  • Isotretinoin / therapeutic use
  • Ivermectin / pharmacology
  • Ivermectin / therapeutic use
  • Laser Therapy / methods
  • Metronidazole / pharmacology
  • Metronidazole / therapeutic use
  • Rosacea / diagnosis*
  • Rosacea / physiopathology*
  • Rosacea / therapy*


  • Anti-Bacterial Agents
  • Metronidazole
  • Brimonidine Tartrate
  • Ivermectin
  • Isotretinoin
  • Doxycycline